These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device. Dobarro D; Urban M; Booth K; Wrightson N; Castrodeza J; Jungschleger J; Robinson-Smith N; Woods A; Parry G; Schueler S; MacGowan GA J Heart Lung Transplant; 2017 Jan; 36(1):42-49. PubMed ID: 27776988 [TBL] [Abstract][Full Text] [Related]
10. Management of Antiplatelet Therapy During Continuous-Flow Left Ventricular Assist Device Support After Thrombotic Hemorrhagic Events. Gallo M; Trivedi JR; Mondal NK; Birks EJ; Slaughter MS ASAIO J; 2019; 65(7):683-689. PubMed ID: 30585872 [TBL] [Abstract][Full Text] [Related]
11. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients. Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD; J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083 [TBL] [Abstract][Full Text] [Related]
12. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre. Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426 [TBL] [Abstract][Full Text] [Related]
13. The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure. Vieira JL; Pfeffer M; Claggett BL; Stewart GC; Givertz MM; Coakley L; Mallidi HR; Mehra MR J Heart Lung Transplant; 2020 Jun; 39(6):582-592. PubMed ID: 32220561 [TBL] [Abstract][Full Text] [Related]
14. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]
16. What is the optimal anticoagulation in patients with a left ventricular assist device? Rossi M; Serraino GF; Jiritano F; Renzulli A Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):733-40. PubMed ID: 22761118 [TBL] [Abstract][Full Text] [Related]
17. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II? Florisson DS; Conte SM; De Bono JA; Newcomb AE Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825 [TBL] [Abstract][Full Text] [Related]
18. Limited Efficacy of Thrombolytics for Pump Thrombosis in Durable Left Ventricular Assist Devices. Seese L; Hickey G; Keebler M; Thoma F; Kilic A Ann Thorac Surg; 2020 Dec; 110(6):2047-2054. PubMed ID: 32348739 [TBL] [Abstract][Full Text] [Related]
19. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes. Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485 [TBL] [Abstract][Full Text] [Related]
20. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]